Potential Catalysts and Strategic Focus: Analyzing Alto Neuroscience's Upcoming Trials and Precision Psychiatry Approach

TipRanksNov 14 02:36 ET

Alto Neuroscience Strengthens Financial Position Amid Increased R&D

TipRanksNov 13 23:44 ET

Alto Neuroscience Analyst Ratings

BenzingaNov 13 10:18 ET · Ratings

Stifel Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Cuts Target Price to $10

Moomoo NewsNov 13 08:31 ET · Ratings

Express News | Alto Neuroscience Inc : Stifel Cuts Target Price to $10 From $32

ReutersNov 13 08:22 ET

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Moomoo NewsNov 13 06:31 ET · Ratings